Viatris, Inc. VTRS 深沪

已收盘 02-06 16:00:00 美东时间

14.58

+0.240

+1.67%

华盛通

立即下载

最高14.60
今开14.24
成交量 845.93万股
最低 14.10
昨收 14.34
总市值 167.93亿
52周最高 14.60
市盈率 ^静 --
换手率 0.73%
52周最低 6.49
委比 -83.39%
总股本 11.52亿
历史最高 16.61
量比 0.82
振幅 3.49%
历史最低 6.49
每手 1
风险率 1.55%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Hikma Pharmaceuticals gains amid takeover speculation

Hikma Pharmaceuticals (HKMPY) may have attracted takeover speculation. Shares of Hikma rose as much as 8.8% in London trading. The identity of the company interested in Hikma (HKMPY) is unclear, accor...

02-05 00:47
Viatris Announces Chief Legal Officer Transition and Successor

An announcement from Viatris ( ($VTRS) ) is now available. On February 3, 2026,...

02-04 06:18
Viatris Inc. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht

Viatris Inc. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht Viatris Inc. wird am 26. Februar 2026 die Finanzzahlen für das vierte Quartal und das Gesamtjahr 2025 veröffentlichen. Das Unternehmen veranstaltet am selben Tag um 8:30 Uhr ET eine Telefonkonferenz, bei der die Ergebnisse von

02-04 05:34
Viatris Inc. publishes update to financial calendar

Viatris Inc. publishes update to financial calendar Viatris Inc. will report its fourth quarter and full year 2025 financial results on February 26, 2026. Company executives will host a webcast to discuss the results at 8:30 a.m. ET on the same date. The live webcast will be available at investor.vi

02-04 05:34
Viatris Names Matthew J. Maletta Chief Legal Officer

Viatris Names Matthew J. Maletta Chief Legal Officer Viatris Inc. has appointed Matthew J. Maletta as Chief Legal Officer, effective February 9, 2026. He succeeds Brian Roman, who will remain as an advisor through April 1, 2026, to support the transition. Maletta brings nearly 30 years of legal expe

02-03 21:30
What Does the Market Think About Viatris Inc?

Viatris Inc's (NYSE:VTRS) short interest as a percent of float has fallen 21.58...

01-30 04:00
美股大行评级 | 希捷科技、德州仪器、HCA控股、通用汽车、波音、UPS等或多家机构上调目标价；布朗保险、康沃系统、Qorvo、联合健康等遭多家机构下调目标价

今日重点评级关注：Piper Sandler：维持Praxis Precision Medicine"超配"评级，目标价从450美元升至1200美元；Tigress Financial：维持Main International ETF"买入"评级，目标价从52美元升至66美元

01-29 11:06
Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $12

Piper Sandler analyst David Amsellem maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $9 to $12.

01-28 22:13
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价

今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元

01-20 10:26
Argus Research Upgrades Viatris to Buy, Announces $15 Price Target

Argus Research upgrades Viatris (NASDAQ:VTRS) from Hold to Buy and announces $15 price target.

01-16 21:44

派息除权日	每股总股息	派息日期
2025-11-24	0.12	2025-12-15
2025-08-22	0.12	2025-09-15
2025-05-23	0.12	2025-06-16
2025-03-10	0.12	2025-03-18
2024-11-22	0.12	2024-12-13
2024-08-23	0.12	2024-09-13
2024-05-23	0.12	2024-06-14
2024-03-08	0.12	2024-03-18
2023-11-22	0.12	2023-12-15
2023-08-23	0.12	2023-09-15
2023-05-23	0.12	2023-06-16
2023-03-08	0.12	2023-03-17
2022-11-22	0.12	2022-12-16
2022-08-23	0.12	2022-09-16
2022-05-23	0.12	2022-06-16
2022-02-23	0.12	2022-03-16
2021-11-22	0.11	2021-12-16
2021-08-23	0.11	2021-09-16
2021-05-21	0.11	2021-06-16
2007-06-27	0.06	2007-07-16
2007-03-28	0.06	2007-04-16
2006-12-27	0.06	2007-01-16
2006-09-27	0.06	2006-10-16
2006-06-28	0.06	2006-07-14
2006-03-29	0.06	2006-04-17
2005-12-28	0.06	2006-01-13
2005-09-28	0.06	2005-10-17
2005-06-28	0.06	2005-07-15
2005-03-29	0.03	2005-04-15
2004-12-29	0.03	2005-01-14
2004-09-28	0.03	2004-10-15
2004-06-28	0.03	2004-07-15
2004-03-29	0.03	2004-04-15
2003-12-29	0.03	2004-01-15
2003-09-26	0.03	2003-10-15
2003-06-26	0.03	2003-07-15
2003-03-27	0.03	2003-04-15
2002-12-27	0.05	2003-01-15
2002-09-26	0.04	2002-10-15
2002-06-26	0.04	2002-07-15
2002-03-26	0.04	2002-04-15
2001-12-27	0.04	2002-01-15
2001-09-26	0.04	2001-10-15
2001-06-27	0.04	2001-07-16
2001-03-28	0.04	2001-04-16
2000-12-27	0.04	2001-01-15
2000-09-27	0.04	2000-10-15
2000-06-28	0.04	2000-07-15
2000-03-29	0.04	2000-04-15
1999-12-29	0.04	2000-01-14
1999-09-28	0.04	1999-10-15
1999-06-28	0.04	1999-07-15
1999-03-29	0.04	1999-04-15
1998-12-29	0.04	1999-01-15
1998-09-28	0.04	1998-10-15
1998-06-26	0.04	1998-07-15
1998-03-30	0.04	1998-04-15
1997-12-29	0.04	1998-01-15
1997-09-26	0.04	1997-10-15
1997-06-26	0.04	1997-07-15
1997-03-26	0.04	1997-04-15
1996-12-30	0.04	1997-01-15
1996-09-26	0.04	1996-10-15
1996-06-26	0.04	1996-07-15
1996-03-27	0.04	1996-04-15
1995-12-27	0.04	1996-01-15
1995-09-27	0.04	1995-10-13
1995-06-29	0.05	1995-07-14
1995-03-27	0.05	1995-04-13
1994-12-23	0.05	1995-01-13
1994-09-26	0.05	1994-10-14
1994-06-24	0.04	1994-07-15
1994-03-25	0.04	1994-04-15
1993-12-27	0.04	1994-01-14
1993-09-24	0.04	1993-10-15
1993-06-24	0.03	1993-07-15
1993-03-25	0.03	1993-04-15
1992-12-24	0.03	1993-01-15
1992-09-24	0.03	1992-10-15
1992-06-24	0.05	1992-07-15
1992-03-25	0.05	1992-04-15
1991-12-24	0.05	1992-01-15
1991-09-24	0.05	1991-10-15
1991-06-24	0.05	1991-07-15
1991-03-22	0.05	1991-04-15
1990-12-24	0.05	1991-01-15
1990-09-24	0.05	1990-10-15
1990-06-25	0.05	1990-07-16
1989-12-22	0.05	1990-01-15
1989-06-26	0.05	1989-07-17
1988-12-23	0.05	1989-01-16
1988-06-29	0.05	1988-07-15
1987-12-24	0.05	1988-01-15
1987-06-24	0.05	1987-07-15
1986-12-24	0.05	1987-01-15
1986-06-24	0.05	1986-07-15
1985-12-27	0.05	1986-01-15
1985-06-24	0.05	1985-07-19
1984-12-24	0.10	1985-01-15
1984-05-21	0.05	1984-06-13
1983-07-11	0.05	1983-08-12
1981-11-16	1.00	1981-11-13

公司名称	Viatris, Inc.
行业分类	--
业务描述	Viatris Inc.于2019年2月14日在特拉华州成立。该公司的业务在医药产品的商业化和制造方面处于全球领先地位，拥有20个全球公认的医药品牌以及一个美国的仿制药平台Greenstone。

Viatris, Inc. VTRS 深 沪

14.58

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Viatris, Inc. VTRS 深沪